From October 1, 2023 to December 31, 2023, the company has repurchased 8,491,700 shares, representing 1.13% for CNY 48.35 million. With this, the company has completed the repurchase of 8,491,700 shares, representing 1.13% for CNY 48.35 million under the buyback announced on January 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 CNY | -0.42% | -5.61% | -14.83% |
1st Jan change | Capi. | |
---|---|---|
-14.83% | 457M | |
+19.64% | 43.3B | |
+21.25% | 22.22B | |
+18.92% | 15.43B | |
+53.19% | 12.72B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B | |
+6.91% | 4.78B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.